Pharmaceuticals

Antiemetics And Antinauseants Market to Reach $9.64 Billion by 2029, Growing at a CAGR of 3.3%

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Antiemetics And Antinauseants Industry Expected To Reach By 2029, Starting From 2025 Levels?

The antiemetics and antinauseants market has consistently expanded in size over recent years. It is anticipated to increase from $8.19 billion in 2024 to $8.48 billion in 2025, growing at a compound annual growth rate (CAGR) of 3.6%. The expansion observed in previous periods can be attributed to factors such as established branding and market competition, historical preferences for treatments, prevailing economic conditions, past global health events, and ongoing medical advancements and research.

The antiemetics and antinauseants market size is projected to experience consistent expansion in the coming years. This market is anticipated to reach a valuation of $9.64 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 3.3%. This expansion during the forecast period can be ascribed to factors such as ongoing research and development efforts, prevailing economic conditions, competitive market dynamics and industry developments, evolving disease patterns, and specific healthcare policies and regulations. Key trends anticipated during this period encompass a heightened emphasis on patient experience, shifts in healthcare policies, a growing consumer inclination towards non-invasive therapies, an increasing occurrence of nausea linked to chemotherapy and pregnancy, and the development of targeted treatments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

Which Drivers Are Supporting Growth Of The Antiemetics And Antinauseants Market?

The rising incidence of cancer significantly propels the antiemetics and antinauseants market. Chemotherapy, a frequently advised treatment for cancer, often leads to side effects such as chemotherapy-induced nausea and vomiting (CINV). Antiemetics are effective in preventing CINV for approximately 60%-70% of patients. As an illustration, The American Cancer Society, a non-profit organization based in the United States, estimated in April 2024 that approximately 609,000 cancer-related fatalities and an expected 1.9 million new cancer diagnoses occurred in the nation in 2022. Furthermore, an estimated 620,000 cancer deaths are anticipated, indicating a slight rise in mortality rates by 2024. This growing occurrence of cancer will consequently boost the demand for antiemetics and antinauseants, thereby fueling market revenue.

What Are The Major Segment Categories Driving The Antiemetics And Antinauseants Market Growth?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

What Key Innovation Trends Are Fueling Advancements In The Antiemetics And Antinauseants Market?

Leading companies in the antiemetic and antinauseant markets are developing novel product innovations, such as ready-to-use injectables, to streamline treatment processes and enhance patient compliance. These pre-mixed formulations are engineered for rapid efficacy, thereby decreasing the duration and intricacy typically involved with conventional injectable medications. For instance, in July 2024, Amneal Pharmaceuticals, a US-based specialty pharmaceutical company, introduced FOCINVEZ, the first ready-to-use injectable formulation of fosaprepitant, designed to prevent acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy. This product is available in a 150 mg/50 mL vial, free of Polysorbate 80, and does not require reconstitution or dilution, allowing for direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older and has been assigned a unique J-Code (J1434) for reimbursement.

Who Are The Major Companies Operating In The Antiemetics And Antinauseants Market?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Which Region Is Projected To Lead The Antiemetics And Antinauseants Market During The Forecast Period?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Antiemetics And Antinauseants Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2025, By The Business Research Company

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Smart Pills Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

Organ On Chip Market 2025

https://www.thebusinessresearchcompany.com/report/organ-on-chip-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795